PAVmed (PAVM)
(Real Time Quote from BATS)
$1.24 USD
-0.09 (-6.77%)
Updated Oct 2, 2024 03:08 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
PAVmed Inc. (PAVM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.67 | $21.00 | $4.00 | 627.07% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for PAVmed Inc. comes to $9.67. The forecasts range from a low of $4.00 to a high of $21.00. The average price target represents an increase of 627.07% from the last closing price of $1.33.
Analyst Price Targets (3 )
Broker Rating
PAVmed Inc. currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on three recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 25% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/10/2024 | Ascendiant Capital Markets | Edward M Woo | Moderate Buy | Moderate Buy |
8/15/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Strong Buy |
8/14/2024 | Cantor Fitzgerald & Co | Ross Osborn | Hold | Hold |
5/15/2024 | Lake Street Capital Markets | Frank Takkinen | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 4 |
Average Target Price | $9.67 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 50 of 252 |
Current Quarter EPS Est: | -1.30 |
PAVM FAQs
PAVmed Inc. (PAVM) currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for PAVmed Inc. (PAVM) is $9.67. The current on short-term price targets is based on 2 reports.
The forecasts for PAVmed Inc. (PAVM) range from a low of $4 to a high of $21. The average price target represents a increase of $627.07 from the last closing price of $1.33.
The current UPSIDE for PAVmed Inc. (PAVM) is 627.07%
Based on short-term price targets offered by three analysts, the average price target for PAVmed Inc. comes to $9.67. The forecasts range from a low of $4.00 to a high of $21.00. The average price target represents an increase of 627.07% from the last closing price of $1.33.